Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-030722

EVP, R&D & Chief Scientific Of sold 25,775 shares at an average $45.30 ($1,167,480)

  • EVP, R&D & Chief Scientific Of acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-05-15 Option exercise +25,000 $11.00 $275,000 357,905 D
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-05-15 Sale −6,885 $44.44 $305,969 351,020 D
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-05-15 Sale −9,638 $45.21 $435,734 341,382 D
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-05-15 Sale −9,252 $46.02 $425,777 332,130 D
Derivatives
Haqq Christopher EVP, R&D & Chief Scientific Of 2018-05-15 Option exercise · Employee Stock Option (Right to Buy) −25,000 25,000 D
Open-market sales · 25,775 sh · avg $45.30 · $1,167,480
Loading xslF345X03/doc4.xml…